View Older Stories View More Recent Stories
-
NVIDIA (NVDA) PT Raised to $360 at Tigress Financial Partners
-
Natural Gas Inventory -132 bcf vs -124 bcf Expected
-
Stifel Reiterates Buy Rating on Tango Therapeutics Inc. (TNGX) following Q4 results
-
Preparing Students for Emerging Roles in Smart Manufacturing
-
Olympic Solidarity Powers Athletes to Historic Medals at Milano Cortina 2026
-
Corporate Volunteering Needs To Change, and It Starts With Us
-
Customer-Obsession, Curiosity, Moonshots: Sumit Singh
-
BofA Securities Reiterates Buy Rating on McKesson (MCK) amid CFO retirement
-
Increasing unusual put option volume: JEPI CMPS BURL EXE UAA WIX EWY JETS LWLG TAP DHT CORT CF UL SHW
-
Increasing unusual call option volume: ALTO CVI WEAT DINO PBF BUG IGV RRC TNYA NMAX BNO NICE EXPE
-
Leerink Partners Reiterates Outperform Rating on CVS Health (CVS), partnership with Google Cloud "positive AI development"
-
SEC Announces Roundtable on Options Market Structure Reform
-
Increasing unusual option volume: ALTO PTRN IONS TNK WEAT EXAS CVI BURL PBF DINO TNYA BNO
-
Popular stocks with increasing option volume: AVGO PLTR NFLX AMD BABA SOFI MSTR HOOD MU
-
ASML Holding NV (ASML:NA) (ASML) PT Raised to EUR1,598 at BofA Securities
-
Active options: GOOGL AMD BABA SOFI MSTR HOOD IREN MU CRCL BULL
-
NextEra Energy (NEE) PT Raised to $104 at UBS
-
Active options: NVDA TSLA AMZN AVGO TTD PLTR AAPL NFLX MSFT
-
National Vision Holdings (EYE) PT Raised to $42 at UBS as 'Game Plan Is Working'
-
UBS Reiterates Buy Rating on Abercrombie & Fitch (ANF) on Long-Term Growth Potential
-
Ross Stores, Inc. (ROST) PT Raised to $208 at UBS, Neutral Rating Reiterated
-
Sight Sciences Inc. (SGHT) PT Lowered to $6.50 at Citi
-
UBS Reiterates Neutral Rating on Bath & Body Works Inc. (BBWI)
-
Meridian Holdings (MRDN): New Name, New Ticker - What To Expect Next?
-
Cracker Barrel (CBRL) PT Raised to $31 at UBS, Neutral Rating Maintained on Limited Visibility
-
UBS Downgrades Sasol Limited (SSL) to Neutral
-
Mattel Inc. (MAT) PT Lowered to $28 at UBS, Estimates Revised
-
Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market
-
Hasbro (HAS) PT Raised to $110 at UBS as Guidance 'Leaves Room for Upside'
-
NexGen Receives Final Federal Approval for the Rook I Uranium Project
-
Jefferies Reiterates Buy Rating on Verastem (VSTM); "catalyst-rich 2026"
-
Zelman & Associates Downgrades Real Brokerage Inc. (REAX) to Neutral
-
Benchmark Reiterates Buy Rating on Ooma (OOMA) as Q4 Results 'Encouraging'
-
Jefferies Reiterates Buy Rating on Helus Pharma (HELP) following Phase 2 data; "add'l data is needed for the Street to have greater confidence"
-
Jefferies Reiterates Buy Rating on HEICO (HEI) following 10-Q
-
Roblox launches AI chat rephrasing to reduce profanity filtering
-
Alkami introduces automated stage match tool for developers
-
Benchmark Reiterates Hold Rating on Cracker Barrel (CBRL)
-
SMX Strengthens Transparency and Security for Australia’s Rare Earth Supply Chains to the US
-
Saint-Gobain Video Series: Success in the Making: Emily Hoffman-Szucs
-
AliMed Launches New Line of Lightweight Hybrid Gel-Foam Positioners Aimed at Improving Safety for Patients and Staff
-
Align Career Design Expands Integrated Coaching Model to Support Whole-Person Career Transformation for Global Leaders
-
Marvell will report earnings today: Here's what analysts expect
-
DC Private Cars Provides Professional Airport Transportation to Major DMV Airports and Regional FBOs
-
FatPipe to Showcase Growth Strategy and Innovation at the 38th Annual ROTH Conference
-
Life EV Completes Rad Power Bikes Asset Acquisition
-
PAR Technology (PAR) PT Lowered to $42 at Benchmark as Stock Down Over 50% Since Mid-Jan
-
BofA Securities Reiterates Buy Rating on Waystar Holding (WAY) amid expanded Google collaboration
-
Benchmark Reiterates Buy Rating on Genius Sports Ltd. (GENI) Post Q4 Results
-
Cantor Fitzgerald Reiterates Overweight Rating on Wix.com (WIX) Amid Focus on NT Margin Expansion
